A high-yielding, generic fed-batch process for recombinant antibody production of GS-engineered cell lines.

An animal-component-free and chemically defined fed-batch process for GS-engineered cell lines producing recombinant antibodies has been developed. The fed-batch process relied on supplying sufficient nutrients to match their consumption, simultaneously minimizing the accumulation of by-products (lactate and osmolality). The proportionalities of nutritional consumption were determined by direct analysis. The robust, metabolically responsive feeding strategy was based on the offline measurement of glucose. The fed-batch process was shown to perform equivalently in GS-CHO and GS-NS0 cultures. Compared with batch cultures, the fed-batch technology generated the greater increase in cell yields (5-fold) and final antibody concentrations (4-8 fold). The majority of the increase in final antibody concentration was a function of the increased cell density and the prolonged culture time. This generic and high-yielding fed-batch process would shorten development time, and ensure process stability, thereby facilitating the manufacture of therapeutic antibodies by GS-engineered cell lines.

[1]  H Li,et al.  Gamma-interferon production and quality in stoichiometric fed-batch cultures of Chinese hamster ovary (CHO) cells under serum-free conditions. , 1997, Biotechnology and bioengineering.

[2]  Andrew J Racher,et al.  Dynamic analysis of GS‐NS0 cells producing a recombinant monoclonal antibody during fed‐batch culture , 2007, Biotechnology and bioengineering.

[3]  B. Buckland,et al.  Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production. , 1997, Biotechnology and bioengineering.

[4]  Ray Field,et al.  Improved Fermentation Processes for NS0 Cell Lines Expressing Human Antibodies and Glutamine Synthetase , 2003, Biotechnology progress.

[5]  R. Field,et al.  Process development for the production of recombinant antibodies using the glutamine synthetase (GS) system , 2006, Cytotechnology.

[6]  T. Bibila,et al.  In Pursuit of the Optimal Fed‐Batch Process for Monoclonal Antibody Production , 1995, Biotechnology progress.

[7]  D. Robinson,et al.  Development of Animal-free, Protein-Free and Chemically-Defined Media for NS0 Cell Culture , 2005, Cytotechnology.

[8]  A. Dickson,et al.  Advances in animal cell recombinant protein production: GS-NS0 expression system , 2000, Cytotechnology.

[9]  J. P. Riley,et al.  A modified single solution method for the determination of phosphate in natural waters , 1962 .

[10]  W. Teo,et al.  Substantial overproduction of antibodies by applying osmotic pressure and sodium butyrate , 1993, Biotechnology and bioengineering.

[11]  S. Kuwae,et al.  Development of a fed-batch culture process for enhanced production of recombinant human antithrombin by Chinese hamster ovary cells. , 2005, Journal of bioscience and bioengineering.

[12]  Daniel I. C. Wang,et al.  Engineering of a mammalian cell line for reduction of lactate formation and high monoclonal antibody production. , 2001, Biotechnology and bioengineering.

[13]  Wei-Shou Hu,et al.  Fedbatch culture and dynamic nutrient feeding. , 2006, Advances in biochemical engineering/biotechnology.

[14]  Yuanxing Zhang,et al.  Enhanced intracellular accumulation of recombinant HBsAg in CHO cells by dimethyl sulfoxide , 2008 .

[15]  L. Häggström,et al.  Defined protein and animal component‐free NS0 fed‐batch culture , 2007, Biotechnology and bioengineering.

[16]  Weichang Zhou,et al.  Protein‐free fed‐batch culture of non‐GS NS0 cell lines for production of recombinant antibodies , 2007, Biotechnology and bioengineering.

[17]  L. Häggström,et al.  Defined Protein‐Free NS0 Myeloma Cell Cultures: Stimulation of Proliferation by Conditioned Medium Factors , 2008, Biotechnology progress.

[18]  Paul W. Sauer,et al.  A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies. , 2000, Biotechnology and bioengineering.

[19]  W M Miller,et al.  Effects of elevated pCO(2) and/or osmolality on the growth and recombinant tPA production of CHO cells. , 1996, Biotechnology and bioengineering.

[20]  Andrew J Racher,et al.  Antibody production. , 2006, Advanced drug delivery reviews.

[21]  Liangzhi Xie,et al.  Applications of improved stoichiometric model in medium design and fed-batch cultivation of animal cells in bioreactor , 2004, Cytotechnology.

[22]  M. Silberklang,et al.  Optimization of a Fed‐batch Process for Production of a Recombinant Antibody , 1994, Annals of the New York Academy of Sciences.